• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (48)

Deal Type

  • (298)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co announces the success of the IPO of Erytech with a Capital Increase of €28 Million

Erytech 2013 tombstone

Bryan, Garnier & Co acts as joint bookrunner for a €45 million private placement for Ablynx

Ablynx 2013 tombstone

Bryan, Garnier & Co advised Mérieux NutriSciences in the acquisition of Chelab

Chelab tombstone

Bryan, Garnier & Co has advised FSI on EUR 15 million investment in DBV Technologies

FSI tombstone

Bryan, Garnier & Co advised Biomain AB in sale to Heraeus Group

Biomain_website_tombstone

Bryan, Garnier and Co advised Santen Pharmaceutical Co. Ltd. on its successful takeover of Novagali Pharma S.A.

Novagali tombstone

Bryan, Garnier & Co advises Cellectis on its acquisition of Cellartis and EUR 50 million capital increase

Cellectis tombstone

€8 million capital raising for PVP Laboratoires SEBBIN Funding led by new investors VENTECH, Idinvest Partners and Sigma Gestion

SEBBIN tombstone

Bryan, Garnier & Co advised bioMérieux in the acquisition of AES Laboratoire

AES tombstone

Bryan, Garnier & Co advises Silliker on its disposal of Dr. A. Verwey

Silliker tombstone

Success of the initial public offering of Zealand Pharma

Zealand Pharma tombstone

Bryan, Garnier & Co advised Synthetech in its sale to W. R. Grace & Co

Synthetech_website_tombstone
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }